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ABSTRACT
STUDIES OF THE STRUCTURES, BIOSYNTHESIS AND FUNCTION OF FUNGAL
GLYCOSPHINGOLIPIDS
by
Elizabeth A. Owuor 
University of New Hampshire, December 2007
Glycosphingolipids (GSLs) are ubiquitously distributed among all eukaryotes. In 
fungi, GSLs have also been implicated in a variety of cellular processes, including 
growth, cell signaling, differentiation and morphogenesis. Detailed knowledge of fungal 
GSL structure and biosynthesis is therefore expected to yield valuable insights into both 
their functions within the organism and their interactions with other organisms, such as 
with the immune system, of an infected host as well as to provide targets for diagnostic 
and therapeutic agents.
Research described in this thesis focused on fungal GSL structure and 
biosynthesis. Two projects are described. The first was aimed at elucidating the functions 
of GSLs in Neurospora crassa. The isolation and structural analysis of 
glycolinositolphosphoryl ceramides (GIPCs) from N. crassa wild type (ATCC 18889 and 
24698) and a defensin-resistant mutant strain (SP 10) were attempted, using NMR, MS 
and other techniques. Although no GIPCs were ultimately isolated in this work, 
phosphatidylinositol, the donor substrate for inositolphosphorylceramide IPC synthase, 
was detected and characterized. In addition, a preliminary study of the effects of an
xiii
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inhibitor of GSL biosynthesis, 4 ’-ethylenedioxy-l-phenyl-2-palmitoyl-3- 
pyrrplidinopropanol (EDO-P4), was performed. The results of this experiment were 
consistent with inhibition of N. crassa glucosylceramide synthase (GCS) by EDO-P4.
In the second project, studies of the structures and biosynthesis of 
glycosphingolipids of the pathogenic model fungus, Cryptococcus neoformans were 
performed on both the wild type (JEC 21) and a mutant, termed ext 1 ext2Its, in which the 
genes for C. neoformans |31,2-xylosyltransfefases, Cxtl and Cxt2 had been disrupted. 
Our results demonstrated an altered expression in GIPC structures in the absence of the 
two xylosyltransferases, characterized by the expression of normal C. neoformans GIPC 
core structure, but without addition of characteristic Xy 1(11,2 residue. We detected no 
residual xylose-containing GIPCs in the cxtlcxt2A mutant sample, confirming that no 
other enzyme performs the function of xylose addition during GIPC synthesis.
xiv
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CHAPTER I
SIGNIFICANCE OF GLYCOSPHINGOLIPIDS
Sphingolipids, along with cholesterol and phosphoglycerolipids, are the three 
major types of lipids found in biological membranes (Dickson et al., 1997). Sphingoids 
are long-chained hydrocarbon bases with a common l,3-dihydroxy-2-amino-backbone 
motif that comprises the defining structural unit of sphingolipids (Figure 1.1).
HN .H
Figure 1.1 The general core structure of a sphingolipid incorporating a long chain 
amino alcohol, commonly (4E)-l,3-dihydroxyl-2-amino-4-octadecene 
(sphingosine), where X = H, R = H: sphingosine; X = H, R = fatty acid: 
ceramide; X = phosphocholine, R = fatty acid: sphingomyelin; X = glycan 
containing head group, R = fatty acid: glycosphingolipid (GSL).
The chain length of the sphingoid is variable, although in mammals and fungi it is 
generally 18-20 carbons. Modifications such as additional hydroxylation, acetylation, 
esterification, unsaturations, and alkyl branching are common features of sphingoids. A 
sphingoid base amide linked to a fatty acid chain is called a ceramide, and the fatty-N- 
acyl chain may also have variations of carbon number and additional modifications such 
as hydroxylation and unsaturation. Ceramides are usually modified (as will be discussed 
later in this section) and very small amounts of free ceramides are found in organisms.
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Mammals and other animal phyla for example, exhibit only one phosphorylated ceramide 
derivative, sphingomyelin, or choline phosphorylceramide, found in quantity in their 
tissues.
Glycosiphingolipids (GSLs) are the O-glycosides of ceramides (Cer) or myo­
inositol- 1 -phosphoryl-1 -ceramides (IPC), (Figure 1.2 and 1.3 respectively), and are 
ubiquitously distributed among all eukaryotes (Kolter and Sandhoff, 1999) and in some 













Figure 1.2 Structure of a prototypical fungal cerebroside with numbering of 
sphingosine (Sph), hexose (Hex), and R3 ; fatty acid (Fa) moieties.
Found mainly in biological membranes, particularly in the plasma membrane, 
GSLs are amphiphilic conjugates, since each is comprised of a polar head group attached
2
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to an iV-acylated sphingoid or ceramide. In GSLs, variations in both glycan and ceramide 
structure may depend on phylum, species, tissue stage of differentiation and development 





Figure 1.3 IPC, the obligate intermediate for the biosynthesis of glycosylinositol 
phosphorylceramide or GIPC found in plants, fungi and other organisms 
but not in mammals (Lester and Dickson 1993). Where Ri=H, spinganines 
or Ri = OH, 4-hydroxysphinganine, commonly referred to as 
phytosphingosine in the phytoceramide. The fatty-N-acyl chain may be of 
typical chain lengths of C22-C26 and be non -hydroxy (R2 = R3 = H), 2- 
hydroxy (R2 = OH, R3 = H; most common in fungi and plants), 2,3- 
dihydroxy (R2 = R3 = OH).
Sphingolipids, like glycerophospholipids and sterols, can play both structural and 
regulatory roles, and their basic lipid building block, ceramide, is considered to be a 
signaling molecule in mammals (Toledo, M.S., et al 2001, Dickson and Lester., 1993, 
1999). Investigations of GSL biosynthesis and function in Saccharomyces cerevisiae 
have established that GSLs are essential components of the fungal membrane. GSLs have 
also been implicated in many cellular processes including growth, differentiation and
3
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morphogenesis in S. commune (Kawai and Ikeda 1982), Cryptoccocus. neoformans 
(Rodrigues et al 2000), P boydii (Pinto et al 2002), Aspergillus nidulans, Aspergillus 
fumigatus (Levery,S., et al 2002) amongst others. GSLs may also modulate cell signaling 
by controlling the assembly and specific activities of plasma membrane proteins 
(Hakomori 1993, Kasahara and Sanai 2000). GSLs on the cell surface are involved in cell 
type specific adhesion processes where they form cell type specific patterns on the cell 
surface, which changes with the differentiation stage and with viral oncogenic 
transformations (Kolter,T. and Sandhoff, K., 1999). Previous studies have shown that 
GSLs can serve as binding sites for toxins, viruses and bacteria. Interactions of GSLs 
with receptors and enzymes, which like themselves are located in the same membrane, 
have been described and are of possible physiological relevance. The ganglioside GM1 
for example, activates the nerve growth factor while the ganglioside GM3 inhibits 
tyrosine phosphorylation of the epidermal growth factor receptor. It is proposed that in 
the attempt to elucidate the functional role of fungal GSLs, systematic isolation and 
characterization of these GSLs should be of interest.
GSLs fall mainly into two categories, neutral and acidic GSLs. 
Monohexosylceramides (CMHs) commonly known as cerebrosides are examples of 
neutral GSLs that contain a monosaccharide, usually glucose or galactose in the beta- 
glycosidic linkage to the 1-hydroxyl of a ceramide. Transfer of a sugar to the ceramide is 
catalyzed by a glycosyltransferase enzyme, yields a monoglycosylceramide, such as |3- 
galactosylceramide (GalCer) or P-glucosylceramide (GlcCer) (Figure 1.2). The ceramide 
moieties in fungal cerebrosides differ structurally in a number of ways that distinguish 
them from mammalian GSLs. (E)-A8 unsaturation and 9-methyl group branching of the
4
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sphingoid base as well as variable levels of (E)-A3 unsaturation of the fatty acid are 
common. Ceramides of fungal cerebrosides are also different from those found in fungal 
GIPCs suggesting that their assembly is from structurally distinct pools of sphingoids. In 
animals, galactose is the common monosaccharide though this may vary with the tissue, 
and the sphingoid is usually sphingosine or dihydrosphingosine.
Glycosylation of ceramide to yield GlcCer or GalCer is of significant importance 
to eukaryotes. It has been proposed, for example, that it protects the mammalian cells 
from cancer drug-triggered apoptosis. Overexpression of GlcCer synthase in MCF-7 
breast cancer cells showed resistance to adriamycin and TNF alpha while in multidrug- 
resistant cells, accumulation of GlcCer was observed. Expression of GlcCer is 
particularly widespread, and inhibition of GlcCer synthase has also been shown to be 
fatal for A. nidulans and A. fumigatus. This suggests that the synthesis of GlcCer is 
essential for growth in fungi. Most importantly, in mammals GlcCer and GalCer are 
intermediates in the biosynthesis of a wide variety of more complex GSLs. In fungi, by 
contrast, these are generally accumulated as terminal products.
A unique class of GSLs found in plants, yeasts, filamentous fungi and protozoans, 
based on the glycosylation of myo-inositol-1 -phosphoryl-1 -ceramides (IPC), has hitherto 
not been found in animal cells, which apparently lack the capacity to synthesize IPC, the 
obligate intermediate in glycosylinositolphosphoryl ceramide (GIPC) biosynthesis 
(Lester and Dickson 1993). GIPCs are a class of acidic GSLs widely distributed among 
fungi and not in mammalian cells or tissues. This group of sphingolipids have also been 
detected in protozoa (including the soil amoeba Acanthamoeba castellanii), plants, and in 
parasitic nematode Ascaris suum (Sugita et al., 1996). Researchers have shown that
5
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fungal GIPCs (or its metabolites) can interact with the mammalian immune system, in 
particular where they present oligosaccharide epitopes not shared with mammalian 
glycoconjugates (Lester and Dickson 1993).
Sphingolipid synthesis begins with the condensation of palmitoyl-CoA and serine 
in the endoplasmic reticulum (Scheme 1.1). This essential irreversible reaction occurs in 
all eukaryotes and is catalyzed by the enzyme serine palmitoyl-transferase (SPT) to 
generate the intermediate 3-ketodihydrosphingosine (3-ketosphingosine). Three genes are 
required for the optimal activity of SPT in S. cerevisiae, LCB1, LCB2 and TSC3, which 
is essential only at elevated temperatures. Other eukaryotes have homologues of LCB1 
and LCB2 and mutations in the mammalian LCB1 homologue (SPTLC1) has been linked 
to hereditary sensory neuropathy type 1 (Dickson and Lester, 2002, Dawkins et al., 2001 
and Bejaoui et al., 2001) suggesting that the synthesis of sphingolipids is regulated in the 
neurons. The second step involves the reduction of 3-ketosphingosine to the long chain 
base, erythro-dihydrosphingosine (DHS, sphinganine) by 3-ketosphingosine reductase, an 
enzyme encoded by the gene TSC10 (Dickson and Lester 2002, Obeid et al., 2002). 
NADPH is also needed for this reaction. The catalytic effects of TsclOp, a membrane- 
bound protein, is essential for this step and its expression in Escherichia coli confirms 
that NADPH is required for the reduction of 3-ketosphingosine to DHS. The third step 
involves the formation of a ceramide, a sphingoid base amide linked to a fatty acid chain. 
Mammalian cells N-acylate DHS using ceramide synthase to generate ‘dihydroceremide’; 
this is later oxidized by the introduction of a trans-4,5 double bond to form ‘ceramide’. A 
first branching point in fungal sphingolipid synthesis is observed after the generation of 
DHS. Instead of being converted to ceramide, the long chain base can be hydroxylated to
6
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yield phytosphingosine (PHS) and then N-acylated to form ‘phytoceramide’, the type of 
ceramide found in inositolphosphorylceramide (IPC), as shown in Scheme 1.1.
S. cerevisiae can only hydroxylate DHS at C-4 to form phytosphingosine (PHS), 
so this is the primary sphingoid base observed in all these cells (85% PHS vs 15% DHS 
in yeast) (24). Hydroxylation of DHS is catalyzed by SUR2, an enzyme found not to be 
necessary for growth. Addition of long chain fatty acids, commonly 16-24 carbons, to 
DHS or PHS then follows, and is catalyzed by the enzyme ceramide synthase. This 
enzymatic activity is encoded by the two genes LAC1 and LAG1; the initial product 
refered to as TV-acylphytosphingosine (Cer-1). This ceramide can then be a-hydroxylated 
on the fatty acid moiety to form phytoceramide (Cer-2); this activity is encoded by the 
SCS7 gene, and has been found to take place in the endoplasmic reticulum of yeasts. 
Further hydroxylation on the fatty-A-acyl 3-carbon yields Cer-3 (not shown).
In Plants and fungi, addition of phosphorylinositol to form 
inositolphosphorylceramide (IPC) is an essential step. The inositol phosphate group of 
phosphatidylinositol is transferred to the C-l OH group of ceramide by IPC synthase, a 
membrane-bound enzyme that is encoded by the AUR1 gene, and inhibition or disruption 
of IPC synthase has been found to be fatal for most fungi. In S. cerevisiae, for example, 
mutants that do not synthesis IPC are not viable (Dickson and Lester 2002; Nagiac et al., 
1997), and pathogenic fungi are killed when treated with compounds such as 
khafrefungin (Mandela et al., 1997), rustmicin (Mandela et al., 1998) and aureobasidin A 
(Takesako et al., 1993; Zhong et al., 2000), inhibitors of IPC synthase. As such, enzymes 
catalyzing the synthesis of phosphorylinositol-containing sphingolipids have been 
considered potential targets for antifungal drugs.
7
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Scheme 1.1 Biosynthetic pathway in the yeast S. cerevisiae starting with palmitoyl 
CoA and serine and ending at the MIPC. The structure of the head-group 
ofM(IP)2C has been omitted in this scheme.
8
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In yeast, IPC is then mannosylated to yield mannose inositol-P-ceramide (MIPC) a 
reaction that requires two genes: CSG1 and CSG2. Mutants in either gene are viable, but 
their deletion prevents MIPC formation and causes IPC accumulation. This step appears 
to be shared by most other fungi.
The derivatives of IPC, mannose-inositol-phosphorylceramide (MIPC), and 
mannose-di(inositolphosphoryl)-ceramide (M[IP]2 C) were first discovered in S. 
cerevisiae as the major GIPCs (Smith and Lester, 1974). Since then, many other studies 
performed by different groups have provided insight into the structures of GIPCs found 
in other fungi. Detailed knowledge of GSL structure and biosynthesis is expected to yield 
valuable insights into both their functions within the organism and their interactions with 
the host immune system, as well as to provide targets for diagnostic and therapeutic 
agents. It has been proposed that enzymatic digestion of the fungal cell wall takes place 
when fungal cells come into contact with that of the host’s. This consequently exposes 
the antigens of the cell membrane and cytosolic contents. GSLs have been shown to 
trigger strong immunological responses in the host when they present different structural 
features from those of the host (Kannagi, R., and Hakomori, S., 1986). GIPCs from 
fungal cell membranes almost always present glycan structural features distinct from 
those of mammals, and can therefore be expected to produce some immunological 
response. Sera of patients with aspergillosis, for example, exhibit strong a reaction with 
GIPCs of A. fumigatus (Toledo et al 2007). It is envisaged that systematic isolation and 
characterization of fungal GSLs will help elucidate their functional roles as well as help 
in understanding their impact in the host’s immune system. Research described in this 
thesis focused on fungal GSL structure and biosynthesis. Two projects are described. The
9
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first was aimed at elucidating the functions of GSLs in Neurospora crassa. The isolation 
and structural analysis of GIPCs from the filamentous fungus N. crassa wild type (WT) 
and a defensin-resistant mutant strain were attempted using NMR, MS and other 
techniques. In addition, a preliminary study of the effects of an inhibitor of GSL 
biosynthesis, 4’-ethylenedioxy-l-phenyl-2-palmitoyl-3-pyrrplidinopropanol (EDO-P4), 
was performed. In the second project, studies of the structures and biosynthesis of GSLs 
of the pathogenic model fungus, Cryptococcus neoformans were performed on both the 
wild type (JEC 21) and a mutant, termed ext 1 ext2A., in which the genes for C. neoformans 
(31,2-xylosyltransferases, Cxtl and Cxt2 had been disrupted.
10
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CHAPTER II
STUDIES OF THE STRUCTURES AND FUNCTIONS OF 
GLYCOSPHINGOLIPIDS OF THE SAPROPHYTIC MODEL FUNGUS,
NEUROSPORA CRASSA
Introduction
Fungi, plants and animals represent three phylogenetic kingdoms within the 
eukaryotes (non bacteria) having similar cellular, genomic and metabolic organizations. 
Fungi rank in importance with bacteria as ubiquitous agents in the biosphere for 
biochemical transformation and environmental housekeeping. In addition, as with 
bacteria and viruses, fungi take part in a multitude of complex interspecies interactions as 
either symbionts or pathogens. As pathogens
(http://biologv.unm.edu/biology/ngpAVhitepaper.html.. 2005), fungi can be problematic 
for development of therapeutic reagents, because of the genetic similarity shared among 
eukaryotes. These shared characteristics, on the other hand, mean that fungi can in many 
respects be used as models for studying cellular processes in other eukaryotes, where the 
degree of genetic and functional similarity is high. For example, like plants and animals, 
the saprophytic filamentous fungus Neurospora crassa exhibits circadian rhythms, and 
thus the sequencing and functional analysis of the Neurospora genome should contribute 
to the understanding of this phenomenon. In general, the numerous genes identified by 
function in N. crassa have enhanced the determination and interpretation of other
11
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eukaryotic genomic DNA sequences. Although it is not considered a pathogen (Ferket, et 
al., 2003), a number of genes in N. crassa are similar to those identified in other fungi as 
being required for plant pathogenesis. This makes N. crassa a suitable model for studying 
some plant-phytopathogen interactions, including those involving plant-derived 
antimicrobial peptides called defensins that target fungal membrane components.
Defensins are small (45-54 amino acids), highly basic, cysteine-rich peptides 
found in a variety of eukaryote species, including plants, and are one family of 
antimicrobial peptides either synthesized in direct response to pathogenic attack or 
constitutively expressed in certain tissues and released or dispersed as a consequence of 
microbial attack or injury. Defensins are also found in other type of organisms (Thomma,
B.P et al., 2002), including insects and humans, and are important components of innate 
immunity. Plant defensins are thought not to be toxic to either mammalian or plant cells, 
and some of these defensins do not display any antimicrobial activities, while others 
demonstrate anti-fungal and antibacterial activities in vitro. Among those exhibiting anti- 
fungal activities, some may have hyper branching effects on specific target fungi (Ferket, 
et al., 2003), while others inhibit growth of fungi without causing morphological changes. 
Studies of Dahlia merckii (dahlia) and Raphanus sativus (radish) defensins indicate that 
they induce rapid responses in fungal membranes, such as alteration of normal membrane 
potential and membrane-permeabilization. Some plant defensins have been shown to 
induce rapid increase of potassium efflux and calcium uptake in N. crassa hyphae. Plant 
defensin membrane permeabilization of N. crassa and S. cerevisiae cells has been 
correlated with inhibition of growth in these species (Thomma et al., 2002; Park et al., 
2005; Thevissen et al., 1996).
12
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The existence of high affinity binding sites for these defensins on fungal cells and 
plasma membrane fractions has been demonstrated (Park et al., 2005; Thevissen et al., 
1996; Thevissen et al., 1998). Considerable evidence has accumulated that in some cases 
these binding sites are GSLs, or at least include GSLs as essential components (Ferket et 
al., 2003; Thomma et al 2002). Mannosylinositol phosphorylceramide (MIPC) and 
mannose-di(inositolphosphoryl)-ceramide (MflPfrC) are the major GIPCs in S. 
cerevisiae, and the latter is thought to be a target of the D. merckii defensin DmAMPl. 
On the other hand, the R. sativus defensins RsAFPl and RsAFP2 appear to interact with 
GlcCer in N. crassa.
Previous studies suggested that there were major differences between wild type 
(WT) and mutant N. crassa strains with respect to expression of both neutral and acidic 
GSLs (Park et al., 2005). Characterization of the neutral GSL, P-glucosyl-ceramide, as 
well as a sterol glycoside, 3-O-P-glucosyl-ergosterol, from both strains, has been carried 
out previously and several differences were identified. These differences correlate with 
the resistance of the mutants to RsAFP2 and other defensins, but the causal relationship 
of these changes, if  any, to defensin resistance remains to be elucidated. In the current 
study, it was expected that the N. crassa model would be used further to elucidate 
functions of GSLs in two ways. First, the isolation and structural analysis of GIPCs from 
N. crassa WT and defensin-resistant mutant strains were to be carried out using NMR, 
MS and other techniques. Secondly, a study of the functions of GSLs in N. crassa using 
an inhibitor of GSL biosynthesis, 4’-ethylenedioxy-l-phenyl-2-palmitoyl-3- 
pyrrplidinopropanol (EDO-P4), was to be performed. EDO-P4 is an inhibitor of 
glucosylceramide synthase (GCS). The inhibitor experiment would allow correlation of
13
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biological effects with changes in expression of GSLs, other lipids, and proteins. In order 
to carry out this study, it was first necessary to determine the viability of the WT strains 
when challenged with increased EDO-P4 concentrations. The point was to determine a 
sub-lethal dose that would enable us to study the effects of GlcCer depletion on lipid and 
protein expression. The hypothesis is that the affected proteins and lipids will be known 
components of transmembrane and other signaling pathways. Preliminary results are 
reported herein.
Materials and Methods 
Fungal isolates and growth conditions
Wild type isolates of TV. crassa strains (ATCC numbers 18889 and 24698), were 
each dispersed in approximately 30 mL sterile deionized water in 100 mL bottles and left 
to stand overnight in a biological safety cabinet at room temperature. 1 mL of each, in 
suspension, was inoculated to six plates containing solid potato dextrose agar (PDA, 
39g/L). The plate cultures were incubated for 4-5 days at room temperature. Cultures of a 
mutant strain termed SP10 were already plated prior to this work, by Steven B. Levery as 
described above. For the purpose of lipid extraction, the plate cultures were transferred to 
500 mL liquid potato dextrose broth (PDB 39g/L) media in 1 L Fembach flasks and 
shaken at 25°C, 250 rpm, for 24 h. Aliquots of each culture were kept at 4°C and used for 
re-plating purposes every three months.
Fresh 10 mL aliquots of each strain in 24 h liquid culture were then inoculated to 
four flasks each containing 1 L of PDB medium, and left to shake at 25°C, 250 rpm, for
14
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2-3 days. Mycelia were harvested by filtration through cheese cloth, washing off excess 
media with deionized water. Excess water was removed by gentle pressure and mycelia 
were either stored at -80°C until extraction, or processed immediately as described 
below.
Solvents for extraction, anion exchange chromatography, and high performance 
thin layer chromatography
Solvent A, chloroform/methanol (1:1; v/v); Solvent B, isopropanol/hexane/water 
(55:25:20 v/v/v, upper phase discarded); solvent C, chloroform/methanol/water (30:60:8 
v/v/v); solvent D, isopropanol/hexane/water (55:40:5 v/v/v); solvent E,
chloroform/methanol/water (60:35:8 v/v/v); solvent F, chloroform/methanol/water 
(50:47:14 v/v/v, containing 0.035% w/v CaCk). All solvents were HPLC grade.
Extraction and fractionation of glycosphingolipids
Extraction and purification of glycosphingolipids were carried out as described 
previously with minor modifications. Briefly, GSLs were extracted by homogenizing 
mycelia (40-80g wet weight) in a glass-walled blender, once with 200 mL of solvent A, 
two times with 200 mL of solvent B and once more with 200 mL of solvent A. The four 
extracts were pooled and dried on a rotary evaporator at 40°C. The extracted lipids were 
then transferred to a 16x100 screw cap test tube, conserving all material by repeatedly 
(3x) adding ~ 4 mL of solvent B, sonicating for ~ 2 min, and transferring. The lipids were 
dried after each transfer under N2 stream at 35-40°C. A final transfer was made using 
solvent A. The dried crude samples of the two WT strains were each taken up in 2 mL of
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solvent C, sonicated, centrifuged, and analyzed by HPTLC (silica gel 60; solvent E) as 
described below.
Crude total lipids from each strain were separately dried down under N2-stream, 
re-suspended in solvent C, and applied to a column of DEAE-Sephadex A-25 (Ac-form, 
in solvent C). Neutral lipids, including putative glucosylceramides (GlcCer) and steryl 
glucosides (GlcSte) were eluted with five bed volumes of solvent C, dried, taken up in 1 
mL of solvent D and analyzed by HPTLC (solvent E). Acidic GSLs were eluted with five 
bed volumes of 0.5M sodium acetate in methanol, dried, resuspended and dialyzed for 
18h against deionized water, changing the water every 6 h. The lipid suspension was then 
recovered, redried, taken up in 1 mL of solvent B, and analyzed by HPTLC (solvent F).
High performance thin layer chromatography (HPTLC)
All HPTLC analysis was performed on silica gel 60 HPTLC plates (E. Merck, Darmstadt, 
Germany). The lipid samples were applied by streaking from 5 pL Microcaps 
(Drummond, Broomall, PA). For analytical HPTLC, detection was made by Bial’s 
orcinol reagent (orcinol 0.55% [w/v] and H2 SO4 5.5% [v/v] in ethanol/water 9:1 [v/v]; the 
plate was sprayed and heated briefly to ~200-250°C; violet staining is positive for the 
presence of hexose). In some cases, a preliminary observation was made by a lipid- 
specific stain, primulin (Aldrich; 0.01% in 80% aqueous acetone, observed under uv- 
light), prior to orcinol detection. Any coloration that appeared bright blue/purple, 
confirming the presence of lipids, was circled, and the plate sprayed further with orcinol 
for analytical comparison. In other cases, the acidic samples were subjected to staining by
16
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Dittmer-Lester reagent, a molybdenum spray specific for phospholipids (any dark blue 
coloration against a light blue background confirms the presence of phosphate) (50).
High performance liquid chromatography (HPLC)
Normal phase preparative HPLC was performed on 5 p micron porous silica (250 x 4.6 
mm Sphereclone, Phenomenex, Torrance, CA). The mobile phase was a 2-propanol- 
hexane-water gradient programmed from 55:40:5 to 55:25:20 (v/v/v) over 120 min, 
followed by isocratic elution for 40 min; flow rate, 0.5 mL/min. The injection volume 
was 1.0 ml and generally, 160 x 0.5 mL fractions were collected in each run and the 
identity and purity of each fraction were assessed by analytical HPTLC (solvent F). 
Fractions that displayed comparatively similar HPTLC Rf-values were combined in 
16x100 screw cap test tubes, dried under N2 , and prepared for further analysis by 1-D *H- 
NMR spectroscopy (as described below).
1H-Nuclear magnetic resonance spectroscopy (NMR)
Samples of underivatized acidic lipid fractions (~ 0.5-1.0 mg) were deuterium exchanged 
(3x) by repeated evaporation from 99.98% D2O using a rotary evaporator, and then 
dissolved in 0.5 mL DMSO-Je/2% D2 O for 1-D 'H-NMR analysis. Spectra were acquired 
at 35°C on a Varian Unity Inova 500 MHz spectrometer using standard acquisition 
software available in the Varian VNMR software package.
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Mass spectrometry (MS)
Mass spectrometry was performed in the positive ion mode via matrix assisted laser 
desorption ionization (MALDI), and electrospray ionization-mass spectromety (ESI-MS). 
Briefly, ESI-MS was performed on a Thermo-Finnegan (San Jose, CA) LCQ with a Pico- 
View nanospray source (New Objectives, Inc., Woburn MA) and LCQ-Tune acquisition 
software. Dried GSL samples were dissolved in methanol, loaded into a 100 pL syringe 
and introduced into the instrument by direct infusion through a nanospray capillary tip at 
an estimated flow rate of 0.5 pL/min. Lithium iodide (Lil) (10 mM in methanol) was 
added to samples for the purpose of generating [M(Li)+Li]+ adducts of the molecular 
species. Lil was added until the observed ratio of [M(Li)+Li]+ adducts to mixed Na+/Li+ 
adducts in the MS profile mode was approximately >5:1. Nominal, monoisotopic m/z 
values are used in the labeling and description of the ESI-MS spectra, which represent a 
summation of 50-150 scans (30 scans /min) for both MS profiles of [M(Li)+Li]+ 
species and MS/CID MS analysis.
Lipidomic analysis of the effects of glucosylceramide synthase inhibitor on N. crassa 
A few modifications were made to the procedures described above in order to determine 
the viability of the N. crassa WT strain ATCC 18889, when challenged with increased 
EDO-P4 concentrations. Briefly, mycelia from plated cultures of ATCC 18889 were 
harvested and transferred to 500 mL liquid potato dextrose broth (PDB 39g/L) media in 
1L Fembach flasks and shaken at 25°C, 250 rpm, for 48 h. Four flasks each containing 
1L PDB medium was prepared. GlcCer synthase inhibitor EDO-P4 dissolved in ethanol 
(4mmol/L), was added to the four flasks consistent with the concentrations 0, 0.5,1.0 and 
20.0pmol/L respectively. 10 mL aliquots of ATCC 18889 were then added into each
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flask and were left to shake at 25°C, 250 rpm, for 2-3 days. Mycelia from each flask were 
harvested, and the extraction, purification and HPTLC analysis of glycosphingolipids 
were carried out in parallel as described earlier.
Results and Discussion
A. Detection, isolation and structural analysis of N. crassa WT and mutant 
GIPCs resistant to plant defensins
HPTLC and NMR results
The HPTLC profiles from the crude total lipids obtained from N. crassa wild type strains 
ATCC 24698 and 18889 are represented in Figure 2.1. As expected, GlcCer was initially 
detected in all the crude total lipid fractions, recognized in the HPTLC analysis by their 
orcinol staining and comigration with an authentic standard, and subsequently in all the 
neutral fractions (Figure 2.2) from the WT N. crassa strains. There did not appear to be 
any striking quantitative differences between the two WT strains. A component 
characterized previously as sterol glycoside having an Rf-value just above GlcCer, is 
known to have been present in low concentrations in WT N. crassa, and is barely 
detectable in these HPTLC profiles. A number of other orcinol+ bands (with lower Rf 
values than GlcCer), which did not co-migrate with any standard compound, were 
observed in these experiments. The neutral fractions from ATCC 18889 that were stained 
with primulin and subsequently by orcinol (Figure 2.3), showed the presence of 
glycolipids at two different Rf-values (bands 1 and 2), besides GlcCer. Some orcinol- 
positive but primulin negative bands were also detected at lower Rf-values and were
19
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
tentatively proposed to be free oligosaccharides. The neutral fractions obtained from the 
ATCC 18889 and SP 10 were then fractionated by preparative-scale HPLC and those 
compounds with similar Rf-values from HPTLC analysis were combined for further 
analysis. The components isolated by HPLC were characterized initially using 1-D 'H- 
NMR and MS, and the identity of a combined neutral fraction (9-12), confirmed as 
GlcCer similar to authentic GlcCer, was in agreement with previously observed results 
(Park et al., 2005). Reproduced in Figure 2.4 Panel A, is the HPTLC profile of the crude 
acidic lipid fractions from N. crassa strains ATCC 18889, 24698 and SP 10, stained with 
orcinol for detection of hexose-containing material, compared with a reference standard 
containing MIPC from P. squamosus.
GlcCer
MIPC
1 2 3 4 5 , 6
Figure 2.1 Profiles of crude lipids from N. crassa WT detected using orcinol. Lanes 2 
and 3 represent the ATCC 18889 strain while lanes 4 and 5 represent 
ATCC 24698 strain. Standards of MIPC (from Polyporus squamosus) and 
GlcCer (from Candida albicans yeast) are represented in lanes 1 and 6 .
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Figure 2.2 Profiles of crude neutral lipids from N. crassa WT detected using orcinol.
Lanes 1, 2 and 3 represent three different batches of the ATCC 18889 
strain, while lane 4 represents the ATCC 24698 strain. GlcCer standard 





Figure 2.3 Profile of crude neutral glycolipids from N. crassa WT detected using 
primulin (marked in pencil) and orcinol. Lane 1 represents the standard 
GlcCer (from Candida albicans yeast), while lanes 2 and 3 represent the 
neutral fractions of ATCC 18889.
Two orcinol stained bands appeared to co-migrate with MIPC in all the three
strains. These appeared in considerably lower abundance than previous analyses,
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however (Park et al., 2005). The crude acidic lipid fractions were then fractionated by 
preparative-scale HPLC. Analytical HPTLC of the fractions, using orcinol and Mo spray 
was used for detection of the relevant compounds, and those with similar Rf-values were 
combined for further analysis.
The partial profile of the HPLC purified acidic fraction number 43-47 from the 
ATCC 18889, (Figure 2.4 Panel B), stained with Mo spray shows the presence of an 
acidic phospholipids (a similar trend was observed in the HPTLC profiles of purified SP 
10 acidic lipids, data not shown). These fractions were combined and subjected to further 
analysis by 'H-NMR spectroscopy.
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Figure 2.4 Profiles of acidic lipid fractions from N. crassa WT. Panel A, detected 
using orcinol. Lanes 2, 3 and 4 represent ATCC 18889, 24698 and SP10 
strains respectively. MIPC standard (from P. squamosus) was used for 
comparison. Panel B, Lanes 2-6, consecutive fractions 43-47 from HPLC 
purified N. crassa (ATCC 18889) acidic lipids, detected using Mo spray. 
These were combined for further analysis.
22
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
The 1-D 1 H-NMR spectrum (DMSO-^6/2% D2 O; 35°C) of acidic fraction 43-47 of the 
ATCC 18889 WT strain is shown in Figure 2.5. Our preliminary assessment was that it 
was not a GIPC, but phosphatidylinositol (myo-inositol-l-phosphoryl-diacyl glycerol). In 
the 2-D TOCSY (Appendix B) spectra, spin systems characteristic for myo-inositol, 
glycerol, and fatty acyl groups were detected; no resonance characteristic for a sphingoid 
moiety were observed. In the absence of GIPCs from the WT and mutant strains, no 
further analysis was made using MS of the acidic fractions.
’ W  4 li l  t . s  j Z-Q 1 , 5  1 . 8
Figure 2.5 1-D 1 H-NMR spectrum (DMSO-<V2% D2O; 35°C) of the acidic fractions
43-47 of the ATCC 18889 wild type strain.
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B. Lipidomic analysis of the effects of glucosylceramide synthase inhibitor on N.
crassa
HPTLC results on the effect of EDO-P4 addition on GlcCer expression
In order to determine a sub-lethal dose that would enable us study the effects of 
GlcCer depletion on lipid and protein expression, it was first necessary for us to 
determine the viability of the WT strain ATCC 18889 when challenged with increased 
EDO-P4 concentrations (0 pM, 0.5 pM, 1.0 pM and 20 pM). There was an inverse 
relationship between the increasing concentrations of EDO-P4 and the wet weights of 
mycelia that were harvested after 48 hours. The wet weights of the mycelia were 4.13g, 
2.83g, 1.60g and 0.63g for the inhibitor concentrations 0, 0.5, 1.0 and 20 pM 
respectively. This information is presented graphically in Figure 2.6. These results 
clearly indicate that EDO-P4 has an effect on viability of N. crassa.
effect of inhibitor concentration on fungal mass
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Figure 2.6 A graph relating the wet weight of the mycelia obtained from N. crassa 
WT 18889 and increasing concentrations (0 pM, 0.5 pM, 1.0 pM and 20 
pM) of EDO-P4
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The HPTLC profiles of crude total lipids in which a range of EDO-P4 concentrations was 
added can be found in Figure 2.7. We observed a band (band 3) in all samples that co­
migrated with the authentic GlcCer standard, although it’s staining appeared at 
decreasing intensities as EDO-P4 concentrations in the media increased. Interestingly 
enough, certain bands with low mobility (bands 4 and 5), that tested positive with orcinol 
staining showed an increase in staining intensity with increase in inhibitor concentration. 
Additionally, the lowest migrating compound, (band 6 ) was also orcinol positive but the 
staining intensity of the bands decreased with increased EDO-P4 concentrations.
In order to analyze further the effect of EDO-P4 on the lipid components, each of 
the four total lipid extracts, representing growth at different concentrations of EDO-P4, 
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Figure 2.7 Profiles of crude lipids from N. crassa ATCC 18889 detected using
orcinol. Lanes 2 and 3 represents lipids form original culture, lanes 4, 5, 6  
and 7 represent inhibitor concentration 0 pM, 0.5 pM, 1.0 pM and 20 pM 
respectively. The streaked amounts were adjusted according to wet weight 
mycelia.
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The HPTLC profiles exhibited a significant decrease in the amount of GlcCer (band 3) in 
samples that had been inoculated with EDO-P4 compared to the control (without 
inhibitor), with a noticeable decrease in the amount of GlcCer with increased inhibitor 
concentrations. This decrease in band intensities suggests that the GCS inhibitor, EDO- 
P4 developed for the mammalian enzyme, also affects GlcCer synthesis in fungi. The 
migration of bands marked 4, were similar to those found in the crude total lipid (bands 4 
and 5). These bands having low mobility tested positive with orcinol staining and showed 
an increase in the amount of components with increase in inhibitor concentration. This 
may have been as a result of accumulation of metabolic intermediates upstream of the 
blocked biosynthetic stage. We did not observe a consistent trend with the lowest 
migrating compounds, bands 5 and 6  (that were also orcinol positive) with increased 
EDO-P4 concentrations. These could be secondary effects of GlcCer depletion or Cer 
accumulation, mediated by signaling networks dependent on normal GlcCer metabolism. 
It is also possible that EDO-P4 has direct effects on other enzymes not related to GCS. 
The HPTLC profiles of the crude acidic fractions obtained from ATCC 18889 are 
represented in Figure 2.9. Although there were several bands that were orcinol positive, 
none of these co-migrated with a fungal Mana2InsPCer (MIPC) standard. Notably, the 
set of bands marked 2 increased in intensity as inhibitor concentration increased. This 
may suggest that there are shared intermediates in the biosynthetic pathways of the two 
fractions (neutral and acidic) and that the inhibition of GCS may have the effect of 
increasing one or more intermediates in the biosynthetic pathways of the acidic fraction.
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Figure 2.8 Profiles of crude neutral lipids from N. crassa ATCC 18889 detected 
using orcinol. Lanes 2, 3, 4 and 5 represent inhibitor concentration 0 pM, 
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Figure 2.9 Profiles of crude acidic lipids from N. crassa ATCC 18889 detected using 
orcinol. Lanes 2, 3, 4 and 5 represent inhibitor concentration 0 pM, 0.5 
pM, 1.0 pM and 20 pM respectively.
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These could also be secondary effects of altered metabolism in cells responding to the 
GCS inhibition. It is also possible as mentioned earlier, that the direct effects of EDO-P4 
are not confined to GCS. Results from HPTLC done using Mo-staining (results not 
shown), were consistent with those of orcinol staining. No bands co-migrated with the 
authentic MIPC standard.
While isolation and analysis of GlcCer from fungi is straightforward, direct assays 
for GCS activities are more difficult to establish (Levery et al., 2003). The effects of 
EDO-P4 on the biosynthetic pathway of GlcCer synthesis may for now be determined by 
analyzing the levels of this cerebroside in the presence or absence of sub-lethal amounts 
of inhibitor. While the results of this experiment were consistent with inhibition of GCS 
by EDO-P4, there were effects on the concentrations of other components in its presence. 
These compounds may be competing for the same ceramide acceptor substrate, although 
a variety of other explanations have not been ruled out, including the possibility that 
EDO-P4 affects the function of other enzymes in fungi that are not affected in mammals. 
Some observed changes could be secondary effects of GlcCer depletion or ceramide 
buildup. The results of this project appear to be in agreement with those observed with 
other fungal models (namely A. fumigatus and A. nidulans (Levry et al., 2003)), 
suggesting that EDO-P4, an inhibitor of mammalian GCS, could be a useful tool in the 
analysis of the physiological functions of GCS in fungi, and may provide important target 
for development of novel classes of antifungal agents, especially as its function(s) 
become better understood.
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CHAPTER III
STUDIES OF THE STRUCTURES AND THE BIOSYNTHESIS OF 
GLYCOSPHINGOLIPIDS OF THE PATHOGENIC FUNGUS, 
CRYPTOCOCCUS NEOFORMANS
Introduction
Over the last two decades there have been rising incidence rates of fatal mycosis 
associated with the growing population of immunosuppressed or -compromised 
individuals, including those with acquired immune deficiency, organ and tissue transplant 
recipients as well as certain cancer cases. Despite attempts at development of new models 
for fungal pathogenicity and strategies for diagnosis and treatment, reports on the 
resistance of mycotic infection to Available antifungal agents are on the increase. This is 
correlated with the emergence of non-susceptible variants within populations of sensitive 
strains. Coupled with the fact that many of the drugs available to treat fungal diseases are 
difficult to administer, are not effective, or are toxic, the emergence of resistant strains 
has made opportunistic fungi an increasing threat to immunosuppressed individuals.
Cryptococcus neoformans is a basidiomycetous fungus ubiquitous in the 
environment, often found in soil, in association with certain trees, and in bird guano 
(Peled et al., 2001). As an opportunistic fungal pathogen, it can infect humans and other 
mammals. Infection begins with inhalation of airborne spores or yeast cells that infiltrate 
the alveoli in the lungs, where it remains dormant in individuals with a competent 
immune system until an immune imbalance triggers further development. Further
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dissemination takes place in immunocompromised hosts, especially those with AIDS, 
with a particular attraction to the central nervous system, where it causes 
meningoencephalitis, a fatal condition if  left untreated. (Bose et al., 2003). Even when 
treated with the most effective antifimgal drugs, cryptococcal infections can be fatal if the 
host does not have adequate T-cell dependent immune function (Mitchelle et al., 2006). 
The pathogenicity of C. neoformans is dependent on various factors. The most notable of 
these include the large polysaccharide capsule; the small cell diameter of 2.5 - 10pm that 
enable the yeast cells to penetrate the alveolar spaces of the lungs, where it establishes a 
pulmonary infection; the synthesis of melanin; and its ability to grow at 37° C, the normal 
temperature within a human host (Moyrand et al., 2002; Klutts et al ., 2007). It has been 
demonstrated that melanin protects the fungus from the host immune response, and 
melanin-deficient mutants of the fungus are avirulent in animals. Although there are 
various factors that make C. neoformans a pathogen, its distinguishing feature, the 
extensive polysaccharide capsule that surrounds its cell walls, is strictly required for its 
virulence in humans and other mammals (Peled et al., 2001). Strains that lack this capsule 
have been shown to be avirulent in animal models, and thus the synthesis of this 
polysaccharide structure can be targeted therapeutically. Three components constitute the 
major part of this enormous capsule. Two xylose-containing polysaccharides, namely 
glucuronoxylomannan (GXM) and galactoxylomannan (GalXM) (Figure 3.1), make up 
about 97% of the capsule mass, while a third component, a polysaccharide conjugate 
called mannoprotein, constitutes the remaining part (Bose et al., 2003).
GXM is a polymer whose backbone consists of mannose residues that are a -1,3- 
linked. This is glycosylated with xylose and glucuronyl side groups the ratio of
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xylose/glucuronic acid/mannose range from 1:1:3 to 4:1:3, depending on the strain, thus 
accounting for four known cryptococcal serotypes, A-D. The backbone of GalXM is 
built on an a - l,6 -linked galactose polymer glycosylated with variable side chains 
containing galactose, mannose and xylose residues (Peled et al., 2001; Bose et al., 2003; 
Klutts et al., 2007).
B
Figure 3.1 Structures of the cryptococcal capsule components. (A) GXM of 
serotype B; (B) GalXM. The structures show the linkages between 
sugars where blue, mannose; gray, glucuronic acid; red, xylose; 
and green, galactose. (39).
Three biosynthetic precursors are required for the synthesis o f GXM, namely 
GDP-mannose, UDP-xylose, and UDP-glucuronic acid; GalXM also requires UDP- 
galactose. Studies have shown that UDP-xylose (UDP-Xyl) is not only a biosynthetic 
precursor, but is also significant for conferring virulence via incorporation into GalXM 
and the four serotypes of GXM. Mutant strains that lack UDP-xylose cannot form the 
capsule and are avirulent in mice. Although the entire biosynthetic pathway of the 
capsule is yet to be elucidated, it has been established that the construction of GXM and
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GalXM require an array of glycosyltransferases, and up to seven xylosyltransferases have 
been found (Klutts et al 2007).
Recent studies on fungal GIPCs obtained from C. neoformans, have reported the 
expression of a variety of xylose branched glycan structures for the first time (34, 40). 
Mendonca-Previato and co-workers recently showed, structural variation between The 
GIPCs of the wild type (KN99a strain) and mutant strains that lack UDP-xylose, brought 
about by disruption of either UDP-glucose dehydrogenase (NE321 strain) or UDP- 
glucuronic acid decarboxylase (NE178 strain). The structures of the GIPCs they 
characterized are represented in Figure 3.2 below. This study further showed that 
mutants that lacked the xylose side chain were unable to complete the elongation of the 
GIPC glycans suggesting that this residue is required for further mannosylation of the 






a-Manp-(l—»6)- a -Manp-(1—G)- a -Manp-(1—>4)-P-Galp-(l—»6)- a -Manp-( 1 —>2)-Ins-1 PCer
Figure 3.2 Structures of Pl-oligosaccharides of GIPCs isolated from C. neoformans.
(A) WT (KN99 a); (B) and (C) mutant strains (NE321and NE178) that 
lack UDP-xylose.
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Figure 3.2 Continued
B. NE321
a -Manp-(1—>3)- a -Manp-(l-^4)-P-Galp-(l—>6 )- a -Man/?-(l—>2)-Ins-lPCer
a -Manp-fl—>2)- a -Man/?-/ 1 —>4)-P-Gal/?-( 1 —>6 )- a -Man/?-(l—>2)-Ins-lPCer
C. NE178
a -Man/?-(l—>2)- a -Man/?-( 1 —>4)-P-Gal/?-( 1 —>6 )- a -Man/?-( 1 —>2)-Ins-1 PCer
The striking similarities between the backbone of GXM, GalXM and the GIPC 
structure of C. neoformans WT is of significant interest to this research. Further, 
pathogenic fungi have been killed by inhibitors of inositol phosphoryl ceramide (IPC) 
synthase (Heise et al.,2002), suggesting that the biosynthesis of phosphoryl containing 
sphingolipids is a promising target for the development of more effective antifungal 
drugs. The focus of this research is in the studies of the structures and biosynthesis of 
glycosphingolipids of the pathogenic model fungus, C. neoformans. Isolation and 
structural analysis was performed on both the WT and the mutant termed cxtlcxt2A, in 
which the xylosyltransferases, Cxtl and Cxt2 have been disrupted. The structural analysis 
was accomplished by a variety of techniques including HPLC, NMR and MS.
Materials and Methods
All experimental methods conducted in this chapter are similar to those in chapter 
2 part A but with minor additions. First, all solvents were the same with an addition of 
solvent G, saturated Butanol; H, methylamine, methanol/water/n-butanol (4/3/1 v/v/v).
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Second, cells of C. neoformans WT (JEC 21) and mutant {ext 1 ext2Is) were obtained from 
our collaborators. Extraction and purification of glycosphingolipids were carried out as 
described previously with minor modifications. Briefly, frozen cells were removed from 
the freezer and left to sit at room temperature for about five minutes in order to just thaw. 
The cells were then immediately transferred to a glass-walled blender and GSLs were 
extracted by homogenizing yeast cells ~40-80g with 200 mL of solvent A. The extract 
was then dried on a rotary evaporator at 40°C. This was followed by butanol extraction 
and base, amine treatment.
Butanol extraction
The dried crude lipid was partitioned between water and butanol pre-saturated 
with water as follows. 2 0 0 ml of distilled water and 2 0 0 ml of saturated butanol were 
added to the crude total lipid in the round bottomed flask. The mixture was shaken 
vigorously for about five minutes and eventually transferred into a separating funnel and 
the aqueous layer that settled at the bottom was collected into the original flask and 
similarly extracted four more times with equal volume of water saturated butanol. The 
upper organic butanol layer was collected in a separate clean round bottomed flask. This 
last step was' repeated four more times, and the five butanol extracts were pooled and 
dried on a rotary evaporator at 40°C.
Base treatment
The dried butanol extract was treated with 20ml of solvent H containing 25-30% 
methylamine at 55°C for 4 h (flask tightly stoppered), with occasional agitation in order
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to destroy the ester linkage due to the diacyl glycerol in the phospholipid. The base 
treated sample was then dried on a rotary evaporator at 55°C and finally transferred to a 
16x100 screw cap test tube, conserving all material by repeatedly (3x) adding ~ 4 mL of 
solvent B, sonicating for ~ 2 min, before transferring. The lipids were dried after each 
transfer under N2 stream at 35-40°C. A final transfer was made using solvent A. The 
dried crude samples of JEC 21 and ext 1 ext2/S. were each taken up in 2 mL of solvent B, 
sonicated, centrifuged, and analyzed by HPTLC (solvent F) before fractionation into 
neutral and acidic lipids as described in chapter 2. The two fractions were analyzed by 
HPTLC and detection was made by Bial’s orcinol reagent.
High performance liquid chromatography (HPLC)
The dried acidic lipid was taken up in 120ml of a mixture of 1:1 vol/vol of solvents B 
and D. Preparative HPLC was then performed as described previously (in chapter 2) over 
160min; flow rate, 0.5 mL/min. Generally, 80 x 1.0 mL fractions were collected in each 
run and the identity and purity of each fraction were assessed by analytical HPTLC 
(solvent F). Fractions that displayed comparatively similar HPTLC Rf-values were 
combined in 16x100 screw cap test tubes, dried under N2; and prepared for further 
analysis by I-D 'H-NMR spectroscopy (as described in chapter 2).
Mass spectrometry (MS)
Mass spectrometry was performed in the positive ion mode on an Electrospray 
Ionization-Mass Spectrometer (ESI-MS) instrument. Briefly, ESI-MS was performed on 
an LTQ equipment with a LCQ-Tune acquisition software. The dried GSL samples were
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dissolved in 200pL methanol, vortexed and centrifuged, and 40 pL of sample introduced 
into the instrument by direct infusion through a nanospray capillary tip at an estimated 
flow rate of 0.5 pL/min. Addition of Lithium Iodide (Lil) (10 mM in Methanol) to 
samples was done for the purpose of generating [M(Li)+Li]+ adducts of the molecular 
species. Although Lil was to be added until the observed ratio of [M(Li)+Li]+ adducts to 
mixed Na+/Li+ adducts in the MS profile mode was approximately > 5:1, this was 
difficult to achieve in most cases given the small sample size. Nominal, monoisotopic 
m/z values are used in the labeling and description of the ESI-MS spectra which represent 
a summation of 50-150 scans (30 scans /min) for both MS [M(Li)+Li]+ and MS/CID 
MS profiles.
Results and Discussion
HPTLC analysis of GIPCs from C. neoformans
The HPTLC profiles from crude GIPCs obtained from wild type (JEC 21) and 
mutant (ext 1 ext2A) cells are represented in Figure 3.3 below. Both strains exhibit a pair 
of bands (Cn-1) that co-migrates with a fungal Mana2InsPCer standard with an 
observable difference in the relative distributions of the bands between monohydroxy- 
(upper) and dihydroxy- (lower) N-acyl forms. More significantly, the GIPCs from JEC 21 
cells express major, low mobility components that are completely absent in the 
cxtlcxt2A  strain. As described in the next section, MS data for these compounds were 
found to be consistent with previously characterized WT GIPCs, 
Mana3(Xyip2)Mana4Gaip6Mana2InsPCer (Cn-5), and
Mana6Mana3(Xyip2)Mana4Gaip6Mana2InsPCer (Cn-6) (Heise et al., 2002, Gutierrez
36
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Figure 3.3 HPTLC profiles of GIPCs (orcinol stained acidic lipid fractions) from C.
neoformans wild type, WT (JEC 21), and mutant (cxtlcxt2A) strains. Lane 
1 represents authentic MIPC standard from Aspergillus fumigatus, lanes 2 
and 3 represent crude GIPCs from the WT and mutant strains respectively.
In contrast, a dark band representing a pair of components with higher mobility, whose
Rf is consistent with a less polar GIPCs than the major wild type species, was observed
as the dominant product in the cxtlcxt2A strain. Based on prior findings (Gutierrez et al
2007; Castle et al, manuscript submitted), these compounds were proposed to be xylose-
free GIPCs with glycan sequence Mana3Mana4Gal(36Mana2InsPCer with two ceramide
lipoforms (Cn-4). We hypothesized that the ext 1 ext2A cells are unable to transfer xylose
from donor UDP-xylose due to deletion of two xylose transferases (Cxtl and Cxt2) and
therefore the GIPCs do not posses the xylose branch in their glycan structure. Our
HPTLC results appeared to indicate that in the absence of these xylosyltransferases, the
cxtlcxt2A cells are unable to transfer xylose to cryptococcal GIPCs. In order to confirm
this, it was necessary to isolate and analyze the GIPCs by mass spectrometry. This was
also done to obtain wild type GIPCs for comparison.
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The crude acidic fractions of both the JEC 21 and cxtlcxt2A were further 
fractionated by HPLC and the identity and purity of each fraction were assessed by 
analytical HPTLC (Figures 3.4 and 3.5 respectively). Fractions that displayed 
comparatively similar HPTLC Rf-values were combined in 16x100 screw cap test tubes, 
dried under N2 , and later analyzed by NMR (results not shown) and mass spectrometry. 
Results of the HPTLC of the relevant HPLC purified fraction are shown below.
A
 M  . 1-4------------- | J .  ,1 i |  t |  ) |  I ,
S 5 7 9 11 13 15 17 19 21 23
B
j S ! I .  .  if i i • J it  ! |  if 4} .4  l 1 -  ‘ 1 5 < i 4 i
S 24 26 28 30 32 34 36 38 40 42
Figure 3.4 HPTLC profiles of GIPCs (orcinol stained acidic lipid fractions) from C.
neoformans WT (JEC 21) strain. Lane 1 represents authentic MIPC 
standard from Aspergillus fumigatus (S) and the subsequent lanes 
represent HPLC purified GIPCs fractions from the WT strain (Panel A; 
HPLC purified fractions numbered 5 through 23, Panel B; HPLC purified 
fractions numbered 24 through 42).
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A.
Figure 3.5 HPTLC profiles of GIPCs (orcinol stained acidic lipid fractions) from C.
neoformans mutant (ext 1 ext2A) strain. Lane 1 represents crude acidic 
fraction of GIPC from the mutant (C) and the subsequent lanes represent 
HPLC purified GIPCs fractions from cxtlcxt2A cells (Panel A; HPLC 
purified fractions numbered 10 through 26, Panel B; HPLC purified 
fractions numbered 27 through 41).
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ESI-MS and -MS" analysis of GIPCs from C. neoformans
A. GIPCs from JEC 21
HPLC purified GIPC fractions from JEC 21 and cxtlcxt2A cells were further 
analyzed using electrospray-ionization-linear ion trap mass spectrometry (ESI-LIT-MS 
and -MS"), in the positive ion mode (+ESI) on a linear ion trap instrument (LTQ, Thermo- 
Finnigan, San Jose, CA). Interpretation of the spectra was consistent with previously 
described reports of purified GIPC components (Levery et al., 1998, 2001, 2005; Bennion 
et al., 2003; Toledo et al., 2007). Molecular profiles of C. neoformans GIPCs as 
[M(Na)+Na]+ salt-adducts were first acquired using +ESI-MS. The major molecular 
species in the JEC 21 profile of one of the earlier eluted combined HPLC fractions, 24-29 
(Figure 3.6), was more complex with two main molecular adduct groups observed at 
nominal, monoisotopic m/z 1132, 1146, 1148, 1160, 1176; and 1618, 1632, 1634, 1646, 
1662 consistent with compositions HexInsPCer and Hex4 lnsPCer, respectively. These 
compositions correspond to the previously characterized GIPC sequences Mana2InsPCer 
(Cn-1) and Mana3Mana4Gal(36Mancx2InsPCer (Cn-4), respectively. The difference of 
m/z 16 between the most abundant peaks within each cluster is consistent with lipoforms 
differing in the degree of hydroxylation of the ceramide fatty-N-acyl group ( t l8:0 4- 
hydroxy-sphinganine with h24:0 and h224:0 fatty acids, respectively). The differences of 
14 or 28 amu between molecular ion signals in each group are consistent with one or two 
additional -CH 2 groups on the sphingoid or fatty acid chain in the ceramide. The 
molecular ions at m/z 1262 and 1485 are not consistent with GIPCs, and are attributed to 
impurities. Overall this fraction appears to contain non-xylosylated intermediates in the 
WT GIPC biosynthetic pathway.
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Figure 3.6 + ESI-MS1 spectra (as [M(Na)+Na]+ salt adducts) of purified GIPC
fraction (24-29) from JEC 21. The peaks labeled X and Y are correspond 
to groups of GIPC adducts with the sequence, Mana2InsPCer (Cn-1) and 
Mana3Mana4Gaip6Mana2InsPCer (Cn-4), respectively. Ions marked 
with asterisk are attributed to impurities. The values in bold are nominal, 
monoisotopiC m/z.
Figures 3.7 and 3.8 (representing profiles of later eluting fractions) are consistent 
with GIPCs having formula Hex4PenInsPCer (m/z 1750, 1766; Figure 3.7 Panels A and 
B) and Hex5PenInsPCer (m/z 1912, 1928; Figure 3.8 Panels A and B). These correspond 
to the previously characterized GIPC sequences
Mana3(Xylp2)Mana4Galp6Mana2InsPCer (Cn-5), and
Mana6Mana3(Xyip2)Mana4Galp6Mana2InsPCer (Cn-6) respectively (Heise et al 
2002). Again the 16 amu difference between each molecular adduct pair is consistent 
with lipoforms differing in the degree of hydroxylation of the ceramide fatty-N-acyl 
group (tl 8:0 4-hydroxy-sphinganine with h24:0 and h224:0 fatty acids, respectively). 
These results show that the low Rf band in the wild type HPTLC profile of JEC 21 
GIPCs (Figure 3.3) corresponds to 4 components: (Cn-5) and (Cn-6), each bearing two 
types of ceramide.
In order to facilitate fragmentation, Lil was added to the GIPC fractions (Levery 
et al 2001, Levery 2005). The addition of Li+ to the GIPCs caused a shift of 32 amu
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(Table 3.1); corresponding to replacement of two Na+ by two Li+ thus the major 
molecular species at m/z 1718 and 1734 in Figure 3.7 Panels C and D correspond to m/z 
1750, 1766 in Figure 3.5 Panels A and B. Likewise the m/z of 1880 and 1896 in Figure 
3.8 Panels G and D correspond to 1912 and 1928 in Figure 3.8 Panels A and B. The 
molecular ion increments of m/z 16 in Figure 3.7 Panels C and D and Figure 3.8 Panels 
C and D correspond to mixed [M(Na)+Li]+ salt adducts arising from insufficient 
lithiation, and not to an additional hydroxyl group on the ceramide. (The way this is 
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Figure 3.7 Mass spectrometry o f GIPC fractions of + ESI-MS1 profiles o f purified 
fractions from JEC 21 consistent with the GIPC sequence, 
Mana3(Xylp2)Mana4Gaip6Mana2InsPCer (Cn-5). Panel A, fraction 39; 
Panel B, fraction 40 (as [M(Na)+Na]+ salt adducts). Panel C and D are 
[M(Li)+Li]+ salt adducts after addition of Lil to fraction 39 and 40, that 
correspond to the [M(Na)+Na]+ salt adducts in Panels A and B. The values 
in bold are nominal, monoisotopic m/z.
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Figure 3.8 Mass spectrometry of GIPC fractions of + ESI-MS1 profiles of purified 
fractions from JEC 21 consistent with the GIPC sequence, 
Mana6Mana3(Xyip2)Mana4Galp6Mana2InsPCer (Cn-6). Panel A, 
fraction 41; Panel B, fraction 42; (as [M(Na)+Na]+ salt adducts). Panel C 
and D are [M(Li)+Li]+ salt adducts after addition of Lil to fractions 41 and 
42, that correspond to the [M(Na)+Na]+ salt adducts in Panels A and B. 
The values in bold are nominal, monoisotopic m/z.
43






I  80 Hit T>
§ 6 0 -  
SI 40H
is
15 20H a: H- aJ.«i Hi. iL
1—i—l—l—I—I—1—I—I—I—I—I—I—I—I—I—I—I—I—I—I—I—I—I—I—I—r








1— I— i i I I I I • I— I I I I I I I 1— I i I’  I I I I— I I I I I I I I— I I I I I "










1200 20001700 1800 19001300 16001000 1100
m/z
B. GIPCs from cxtlcxtA
The MS1 profiles obtained from GIPC fractions 29 and 30 of the ext 1 ext2A 
mutant are shown in Figure 3.9 (Panels A and B, respectively). Each of the major 
molecular adduct species [M(Na)+Na]+observed, m/z 1132 (fraction 29) and, m/z 1148 
(fraction 30), is consistent with the composition HexInsPCer, and corresponds to the 
previously characterized GIPC with the sequence Mana2InsPCer. The 16 amu difference
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between these molecular adduct pair m/z 1132 and 1148 is again consistent with 
lipoforms differing in the degree of hydroxylation of the ceramide fatty-N-acyl group 
(tl 8:0 4-hydroxy-sphinganine with h24:0 and h224:0 fatty acids, respectively). Further, 
the major molecular adduct species observed at m/z 1132, 1146 and 1160 in panel A are 
consistent with HexInsPCer with ceramides containing t l 8:0 4-hydroxysphinganines 
h24:0, h25:0 and h26:0 fatty N-acylation respectively. This pattern is also observed with 
the peaks at m/z 1148, 1162 and 1176 in panel B. As before the fractions were treated 
with Lil to facilitate fragmentation in MS” modes. Figure 3.9 Panel C exhibits the major 
molecular adduct species [M(Li)+Li]+ after lithiation m/z 1100 (corresponding to 
[M(Na)+Na]+ m/z 1132). In this case the adduct at m/z 1116 represents underlithiation. 
The ESI-MS2 spectra (Figure 3.9, Panel D) acquired from the molecular adduct: at m/z 
1100 exhibits ceramide containing ions [ZoPC>3 ( L i ) + L i] + at m/z 758, [YoPC>3 ( L i ) + L i] + at 
m/z 776, [Y o + L i] + and [Z o + L i]+ at m/z 690 and 672 respectively. ESI-MS3 of the ion at 
m/z 690(Appendix C) provides evidence on the mass of the sphingoid [0/ Yo +Li]+ and 
by subtraction from [Y o +Li]+, the mass of the fatty acid as well. Glycosidic cleavages 
with or without phosphate are well represented in the fragmentation of the glycolinositol. 
An abundant pair of phosphorylglycolinositol fragments is observed at m/z 417 an 435 
for [HexInsPLi2]+, ([B2PC>3 (Li)+Li]+ and [C2PC>3(Li)+Li]+ respectively). A pair of non- 
phosphorylated fragments representing the non-reducing end of glycosylinositol are 
observed at m/z 331 and 349 for [Hex.Ins+Li]+, ([B2+Li]+ and [C2+Li]+ respectively). 
These cleavages are summarized in Scheme 3.1, Table 3.2 and Appendix A.
On the whole, lithiation of samples reduces the m/z of molecular species by 32 
(Table 3.1), and is expected to simplify MS parent ion profiles as well as increasing the 
overall signal to noise (S/N) compared to [M(Na)+Na]+ adducts in MS” profiles (Levery 
et al 2001; Levery et al 2005). It is sometimes difficult, however, to achieve complete 
lithiation before the signal becomes suppressed by the high salt concentration. As a result 
it is common to observe some residual mixed salt adducts of GIPCs in these spectra
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(Levery et al 2001, Levery et al 2005). This is evident, for example, from the peak at m/z 
1116 in Figure 3.9, Panel C (corresponding to [M(Na)+Na]+ m/z 1132). At low 
resolution the shift of +16 amu could suggest either an addition of a hydroxyl group to 
the ceramide or insufficient lithiation. In order to establish the difference, an MS of the 
+16 adduct was acquired (Figure 3.9, Panel E). although the +16 increment to all the 
ceramide related ions e.g., at m/z 758 (from the parent ion m/z 1100) and m/z 774 (from 
the parent ion 1116), might suggest an extra hydroxyl group attached to the ceramide, the 
same +16 amu increment on the glycosylinositol phosphate ions, m/z 433 and 451 from 
the m/z 1116 parent ion compared to m/z 417 and 435 from the m/z 1100 parent ion 
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Figure 3.9 Mass spectrometry of GIPC fractions of + ESI-MS1 profiles of purified 
fractions from ext 1 ext2A consistent with the GIPC sequence, 
Mana2InsPCer (Cn-1). Panel A, fraction 29; Panel B, fraction 30 (as 
[M(Na)+Na]+ salt adducts ) Panel C, MS1 of fraction 29 after addition of 
Lil. Panels D and E represent the MS2 spectra of [M(Li)+Li]+ at m/z 1100 
and 1116 respectively. The values in bold are nominal, monoisotopic m/z.
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Scheme 3.1 Fragmentation of [M(Li)+Li]+ at m/z 1100 consistent with the structure 
Mana2InsPCer (Cn-1) in +ESI-MS2; fragment designations as in Costello 
and Vath (Costello, 1990) as expanded for GIPCs in Singh et al (Singh,
1991). The additional lithium ion has been omitted.
An +ESI-MS1 profile of later a eluting HPLC purified GIPC fraction from 
cxtlcxt2A, that represent additional glycosylation on the Mana2InsPCer GIPC structure, 
is presented in Figure 3.10, Panel A. The major molecular adduct species [M(Li)+Li]+ in 
the + ESI-MS1 profile, consistent with the composition Hex2lnsPCer (m/z 1262, 1278 and 
1290) are observed in Figure 3.10, Panel A. These values show a uniform increment of 
162 to the first group of ions (m/z 1100,1116 and 1128), observed in Figure 3.9, Panel C 
consistent with the addition of a second hexose residue to (Cn-1). The Hex2 lnsPCer 
composition corresponds to the previously characterized GIPC sequences 
Gaip6Mana2InsPCer (Cn-2) (Heise et al 2002). Again the 16 amu difference between 
each molecular adduct pair is consistent with lipoforms differing in the degree of
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hydroxylation of the ceramide fatty-N-acyl group (tl8:0 4-hydroxy-sphinganine with 
h24:0 and hi24:0 fatty acids, respectively). +ESI-MSn spectra for the molecular adduct at 
m/z 1262 (Figure 3.10, Panels B, C and D) exhibit fragmentations consistent with 
Scheme 3.2. An abundant pair of glycosylinositol phosphate fragment is observed at m/z 
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Figure 3.10 Mass spectrometry of GIPC fractions (as [M(Li)+Li]+ salt adducts ) of 
+ESI-MS1 profiles of purified fractions from ext 1 ext2k. Panel A, fraction 
33 is consistent with the GIPC sequence, Gaip6Mana2InsPCer (Cn-2). 
Panel B, +ESI-MS2 (m/z 1262 —>) spectrum of selected [M(Li)+Li]+ salt- 
adduct m/z 1262 (Hex2InsPCer); Panel C and D, +ESI-MS3 (m/z 1262 -> 
579 —> and m/z 1262 —> 417 —») spectrum originating from the same 
molecular species. The values in bold are nominal, monoisotopic m/z.
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A pair of phosphorylglycolinositol fragments is observed at m/z 417 an 435 for 
[HexInsPLi2]+ ([Y2/B3P 03(Li)+Li]+ and [Y2/C3P 0 3(Li)+Li]+ respectively, Panel C). An 
additional pair [InsPLi2j+ is observed in the MS3 spectrum (Panel D) at m/z 255 and 273 
Yi/[B3P 0 3(Li)+Li]+ and Yi/[C3P 0 3(Li)+Li]+, respectively). A pair of non-phosphorylated 
fragments representing the non-reducing end of glycosylinositol is observed at m/z 493 
and 511 for [Hexlns+Li]+, ([B3+Li]+ and [C3+Li]+ respectively) (Panel B). Other non- 
phosphorylated fragments are observed at m/z 349 [C2+Li]+, 331 [B2+Li]+, 187 [Q+Li]+ 
and 169 [ B i+ L i] +. A ceramide containing ion [ Z o P 0 3( L i ) + L i] + (Panel B )  is observed at 
m/z 758 and 0 / ( [ Z o P 0 3( L i ) + L i] + at m/z 392. Other ceramide related fragmentations were 
observed at m/z 776 ([Y0PO3(Li)+Li]+), [Y0 +Li]+ and [Z0+Li]+ at m/z 690 and 672 
respectively (Panel B).
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Scheme 3.2 Fragmentation of [M(Li)+Li]+ at m/z 1262 consistent with the structure 
Gaip6Mana2InsPCer (Cn-2) in +ESI-MS2 and-MS3; Fragment 
designations as in Costello and Vath (Costello, 1990) as expanded for 
GIPCs in Singh et al (Singh, 1991). The additional lithium has been 
omitted.
In the +ESI-MS1 profiles of the most complex GIPCs obtained from 
cxtlcxt2A cells, (Figure 3.11, Panels A and B). We observed the major molecular adduct 
species [M(Li)+Li]+ consistent with the composition Hex4 lnsPCer (m/z 1586 and 1602 
respectively). These values show a uniform increment of 324 to m/z 1262 and 1278 
(Figure 3.10, Panel A), and is consistent with the addition of two hexose residues to (Cn- 
2). The Hex^nsPCer composition corresponds to the previously characterized GIPC 
sequence Mana3Mana4Gaip6Mana2InsPCer (Cn-4). No traces of xylosylated GIPC 
products in the profile of ext 1 ext2A were detected. To confirm the lack of xylose in the
51
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mutant GIPC molecular species, the major molecular adduct corresponding to m/z 1586 
was selected for further fragmentation by +ESI-MSn mode (Figure 3.11 Panel D and E). 
+ESI-MS2 spectrum acquired from the [M(Li)+Li]+ peak at m/z 1586 (corresponding to 
[M(Na)+Na]+ m/z 1618 (Na+ data not shown)) of the ext 1 ext2A mutant profile showed the 
predominant glycosylinositol phosphate fragments [B5PC>3(Li)+Li]+ and [C5P0 3 (Li)+Li]+ 
pair (m/z 903 and 921) corresponding to Hex4nsP, and other fragments from glycosidic 
cleavages (Scheme 3). A ceramide ion (Yo+Li+) was observable at m/z 690 (h24:0/tl8:0 
lipoform). A +ESI-MS3 spectrum acquired from the [C5P0 3 (Li)+Li]+ ion at m/z 921 (m/z 
1586 921 Figure 3.11, Panel D and E) showed all of the glycosidic cleavages
consistent with a linear Hex4nsP primary fragment (Scheme 3.3). Essentially identical 
spectra were acquired from the [M(Li)+Li]+ salt-adduct at m/z 1602 (corresponding to 
[M(Na)+Na]+ m/z 1634) (not shown), except that the ceramide ion was observed in the 
MS2 spectrum at m/z 706 (h224:0/tl8:0 lipoform).
^—i—i i i—|—i—i—i—i—|—i—i—i—i—|—i—i—r—i—p-i—i—i—i—|—nr—i- t—|—i—r—i—i—|—i—r-*i—i—p
1000 1100 1200 1300 1400 1500 1600 1700 1800
m/z
Figure 3.11 Mass spectrometry of GIPC fractions of + ESI-MS1 profiles of purified 
fractions from ext 1 ext2A consistent with the GIPC sequence 
Mana3Mana4Gal|36Mana2InsPCer(Cn-4). Panel A, fraction 35-36; Panel 
B, fraction 37-38 (as [M(Li)+Li]+ salt adducts). Panel C, MS2 spectrum of 
[M(Li)+Li]+ at m/z 1586. Panels D and E represent the MS3 spectra of 
[M(Li)+Li]+ at m/z 1586 —» 921 —» and m/z 1586 —> 903 —» . The values 
in bold are nominal, monoisotopic m/z.
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Scheme 3.3 Fragmentation of [M(Li)+Li]+ at m/z 1586 consistent with the structure 
Mana3Mana4Gaip6Mana2InsPCer (Cn-4) in +ESI-MS2 and -MS3; 
Fragment designations as in Costello and Vath (Costello, 1990) as 
expanded for GIPCs in Singh et al (Singh, 1991). The lithium adduct and 
ion have been omitted.
These results demonstrate an altered expression in GIPC structures in the absence 
of the two xylosyltransferase, Cxtlp and Cxt2p. Lack of xylose modification in 
cxtlcxt2A cells is accompanied by truncation of the terminal mannose residues distal to 
the branch. Furthermore, we detect no residual xylose-containing GIPCs in the ext 1 ext2A 
mutant sample, indicating that no other enzyme performs the function of xylose addition 
during GIPC synthesis. This study shows that either Cxtlp or Cxt2p, or both, are
54
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xylosyltransferases that are involved in the biosynthetic pathway of GIPCs in C. 
neoformans.
55
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Table 3.1 Respective species from C. neoformans depicting both the Molecular 
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Table 3.2 (A) Molecular adduct ion [M(Li)+Li]+ observed in ESI-LIT-MS profile,
(B) and significant ceramides-containing, (C) glycosylinositol ions and 
(D) non-phosphorylated glycan derived from GIPC consistent with the 
(Cn-1) structure. Fragment designations as in Costello and Vath (Costello,
1990) as expanded for GIPCs in Singh et al (Singh, 1991) with 
modifications o f ceramide-derived ions from Adams and Ann (Adams, 
1993).
Fraction 29
Fatty Acid . h24:0
Sphingoid tl 8:0
A. [M(Li)+Li]+ 1100
Product of [M (Li)+Li]+:







[C2P 0 3(Li)+Li]+ 435
[B2P 0 3(Li)+Lif 417
D. Non Phosphorylated glycan
[C2+Li]+ 349
[B2+Li]+ 331
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Table 3.3 (A) Molecular adduct ion [M(Li)+Li]+ observed in ESI-LIT-MS profile,
(B) and significant ceramide-containing, (C) glycosylinositol ions, (D) 
inositol ions and (E) non-phosphorylated glycan derived from GIPC 
consistent with the (Cn-2) structure. Fragment designations as in Costello 
and Vath (Costello, 1990) as expanded for GIPCs in Singh et al (Singh,






Product of [M (Li)+Li]+:







[C3P 0 3(Li)+Li]+ 597
[B3P 0 3(Li)+Li]+ 579
Y2/[C3P 0 3(Li)+Li]+ 435
Y2/[B3P 0 3(Li)+Li]+ 417
D. Inositol ions
Y i/[C3P 0 3(Li)+Li]+ 273
Y i/[B3P 0 3(Li)+Li]+ 253
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Table 3.4 (A) Molecular adduct ion [M(Li)+Li]+ observed in ESI-LIT-MS profile,
(B) are significant ceramide -  containing, (C) glycosylinositol ions, and 
(D) non-phosphorylated glycan derived from GIPC consistent with the 
(Cn-4) structure. Fragment designations as in Costello and Vath (Costello, 
1990) as expanded for GIPCs in Singh et al (Singh, 1991) with 






Product of [M (Li)+Li]+:







[C5P 0 3(Li)+Li]+ 921
[B5P 0 3(Li)+Li]+ 903
Y4/[C5P 0 3(Li)+Li]+ 759
Y4/[B5P 0 3(Li)+Li]+ 741
Y3/[C5P 0 3(Li)+Lif 597
Y3/[B5P 0 3(Li)+Li]+ 579
Y2/[B5P 0 3(Li)+Li]+ 417
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CHAPTER IV
FUTURE STUDIES
In the present research, HPTLC and NMR were used to provide information about 
the structures of the acidic GSLs obtained from N. crassa WT and the defensin-resistant 
mutant SP 10. Whereas no GIPCs were detected, further work needs to be performed on 
this fraction, using other techniques such as mass spectrometry for detailed 
characterization. Also, although characterization of the neutral GSL, p-glucosyl- 
ceramide, as well as a sterol glycoside, 3-O-p-glucosyl-ergosterol, from both strains, had 
previously been carried out, and several differences that correlated with the resistance of 
the mutants to RsAFP2 and other defensins had been identified, we observed from the 
HPTLC profiles of the neutral fraction, a number of other orcinol+ bands (with lower Rf 
values than GlcCer), which did not co-migrate with any standard compound. Further 
work involving the identity of these compounds is called for.
While isolation and analysis of GlcCer from fungi is straightforward, direct assays
\
for GCS activities are more difficult to establish. We however managed to determine that 
a concentration of 1 pM would provide a useful compromise between inhibitory effect 
and yield of mycelia. While the results of this experiment were consistent with inhibition 
of GCS by EDO-P4, there were effects on the concentrations of other components in its 
presence. A variety of possible explanations were provided in the text. The identities of 
these compounds still remain uncharacterized. Further research including characterization 
of these unknowns as well as performing a correlation study of biological effects with
60
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
changes in expression of GSLs, other lipids, and proteins is needed. These changes would 
enable us learn more about possible pathways and functions of GlcCer and why 
inhibition of its synthesis is lethal to fungus.
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APPENDICES
APPENDIX A
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Characteristic fragmentations of glycosylated IPCs. A: Nomenclature of Adams and Ann 
for fragmentation of the ceramide moiety, and of Singh, Costello, and Beach for the myo­
inositol phosphoryl group. B: Sphingoid d3b ion, proposed by Hsu and Turk. C: Hydrated 
analog of d3b ion, proposed in this study as a product of tl 8:0 or t20:0 phytosphingosine- 
containing ceramides. D: Sphingoid Cib ion, proposed by Hsu and Turk. E: Hydrated 
analog of cib ion.
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Downfield expansions (5.48-2.06) of two-dimensional (2-D) 1H-NMR spectrum (500 
MHz; 200msec; DMSO-^/2% D2O; 35°C) of the acidic fractions 43-47 of the ATCC 
18889 wild type strain of N. crassa. The aeyl-chain and np/o-inositol are represented by 
the spin systems at 5.1-3.7 and 3.8-2.9 respectively.
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APPENDIX C
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700200 300 400 800
+ESI-MS3 mass spectrometry profile of GIPC purified fraction 29 from cxtlcxt2A 
consistent with the GIPC sequence, Mana2InsPCer (Cn-1 (m/z 1100 —» 690 ->) (as 
[M(Li)+Li]+ salt adducts).
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